Kymera Therapeutics, Inc. · NASDAQ:KYMR
Chadwick Jeremy G sold 6,551 Kymera Therapeutics, Inc. shares (Form 4)
Traded Apr 14 to Apr 15, 2026 · Filed Apr 16, 2026
From Apr 14 to Apr 15, 2026, Chadwick Jeremy G (Chief Operating Officer) sold 6,551 Kymera Therapeutics, Inc. shares at US$90.00 for US$590K under a trading plan, leaving 61,202 shares. Filed Apr 16, 2026 (Form 4).
- Sold
- 6,551 shares
- Price
- US$90.00
- Value
- US$590K
- Holding after
- 61,202 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 14, 2026 | Common Stock | Option exercise | 4,466 | US$30.17 | 65,668 | Direct |
| Apr 14, 2026 | Common Stock | Option exercise | 785 | US$43.50 | 66,453 | Direct |
| Apr 14, 2026 | Common Stock | Sale | 5,251 | US$90.00 | 61,202 | Direct |
| Apr 15, 2026 | Common Stock | Option exercise | 1,300 | US$43.50 | 62,502 | Direct |
| Apr 15, 2026 | Common Stock | Sale | 1,300 | US$90.00 | 61,202 | Direct |
Source
Related
- Kymera Therapeutics, Inc.
- Chadwick Jeremy G
- Kymera Therapeutics, Inc. shareholders
- Form 4 · Chadwick Jeremy G · May 27, 2026
- Form 4 · Chadwick Jeremy G · Apr 24, 2026
- Form 4 · Chadwick Jeremy G · Apr 1, 2026
- Form 4 · Mainolfi Nello · Oct 1, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Sep 8, 2026
- Form 4 · Adams Brian · Sep 4, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Atlas Venture Fund X, L.P. · Aug 13, 2026